At a glance
ClinicalIndex Comparison RecordN/ACompleted· 74 enrolled
Drug / intervention
MiniMed™ 670G systemdevice
Likely dose
MiniMed™ 670G systemfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Safety, Effectiveness and Usability Evaluation of the Hybrid Closed Loop (HCL) System in Type 1 Adult and Adolescent Subjects in Chinese Population
In Brief
A clinical study evaluating MiniMed™ 670G system for Diabetes Mellitus, Type 1. Completed, enrolled 74 participants across 4 sites.
Detailed Summary
The purpose of this study is to obtain clinical data in Chinese patients to support product registration of the MiniMed™ 670G system with the National Medical Product Administration (NMPA) in China. The results from the study will be submitted to the NMPA for product registration.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes Mellitus, Type 1
CountriesChina
Collaborators--
Timeline
N/ACompletedFinished
202120222023202420252026
Enrollment StartOct 2020
First PostedDec 2020
Primary CompletionJun 2021
TodayJul 2026
First PostedDec 11, 2020
Enrollment StartOct 31, 2020
Primary CompletionJun 22, 2021
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 5.6 years ago
Interventions
MiniMed™ 670G systemdevice
Hybrid closed loop insulin pump with associated CGM and blood glucose meter